Glutamate‐evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue
Authors:
Open Access
- 1 April 1987
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 90 (4) , 641-650
Abstract
The present study examined the effect of a selective δ‐opioid receptor agonist [d‐Ala2‐d‐Leu5] enkephalin (DADL) on the spontaneous and thel‐glutamic acid (l‐Glu)‐evoked release of endogenous dopamine from superfused slices of rat caudate‐putamen. The amount of dopamine in slice superfusates was measured by a sensitive method employing high‐performance liquid chromatography with electrochemical detection (h.p.l.c.‐e.d.) after a two‐step separation procedure. The spontaneous release of endogenous dopamine was (a) partially dependent on Ca2+, (b) enhanced in Mg2+‐free superfusion medium, (c) partially reduced by tetrodotoxin (TTX, 0.3 μm), (d) partially reduced by the putative excitatory amino acid receptor antagonistdl‐2‐amino‐7‐phosphonoheptanoic acid (dl‐APH, 1 mm), and (f) increased 10 fold by the dopamine uptake blocker, nomifensine (10 μm). DADL (5 and 50 nm) did not significantly affect spontaneous dopamine release. l‐Glu (0.1–10 mm) produced a concentration‐dependent release of endogenous dopamine from slices of caudate‐putamen. This effect was (a) Ca2+‐dependent, (b) strongly inhibited by 1.2 mmMg2+, (c) attenuated bydl‐APH (1 mm), (d) attenuated by TTX (0.3 μm), and (c) enhanced by nomifensine (10 μm). In the presence of nomifensine DADL (50 nm) reduced significantly thel‐Glu‐evoked release of endogenous dopamine by 20%. The inhibitory effect of DADL was blocked by 10 μmnaloxone. These results indicate thtl‐Glu stimulates the Ca2+‐dependent release of endogenous dopamine in the caudate‐putamen by activation of N‐methy‐d‐aspartate‐type of excitatory amino acid receptors. This release can be selectively modified by the δ‐opioid agonist DADL in a naloxone‐sensitive manner.Keywords
This publication has 26 references indexed in Scilit:
- κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine releaseNature, 1984
- Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differencesPeptides, 1983
- Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acidCanadian Journal of Physiology and Pharmacology, 1983
- Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminalsNeurochemistry International, 1982
- Presynaptic Control of the Synthesis and Release of Dopamine from Striatal Synaptosomes: A Comparison Between the Effects of 5‐Hydroxytryptamine, Acetylcholine, and GlutamateJournal of Neurochemistry, 1980
- Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileumLife Sciences, 1979
- STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONSJournal of Neurochemistry, 1979
- Opiate Peptide Modulation of Amino Acid Responses Suggests Novel Form of Neuronal CommunicationScience, 1978
- Morphine and β-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatumNature, 1978
- β-Endorphin in vitro inhibition of striatal dopamine releaseNature, 1976